Notably, in metastatic cases with KRAS mutation detected by tumor tissue testing, KRAS detection in LB was associated with worse OS (HR = 2.57, 95%CI = 1.42–4.63, P = 0.002; Fig. 2-F). This evidence concerns the gene KRAS and neoplasm.